Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$43.91 +1.86 (+4.42%)
At close: Nov 10, 2026 · 4:00 PM EST

Rigel Pharmaceuticals (RIGL) Current Leases (2010 - 2011)

Updated

Rigel Pharmaceuticals (RIGL) recorded Current Leases of $134,000 in Q3 2011, down 57.5% from the prior quarter.

Analysis

Rigel Pharmaceuticals (RIGL) Current Leases (2010 - 2011) Analysis & Trends

At the end of FY2010, Rigel Pharmaceuticals reported Current Leases of $755,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Rigel Pharmaceuticals 801.35 Mn 305.08 Mn 70.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 134,000.00
Jun 30, 2011 315,000.00
Dec 31, 2010 755,000.00
API Access

Rigel Pharmaceuticals Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=RIGL&period=max&api_key=YOUR_API_KEY